Last Updated: June 17, 2026

ORTHO-CEPT Drug Patent Profile

✉ Email this page to a colleague

When do Ortho-cept patents expire, and what generic alternatives are available?

Ortho-cept is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ORTHO-CEPT is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ortho-cept

A generic version of ORTHO-CEPT was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12^th, 1999.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ORTHO-CEPT?
What are the global sales for ORTHO-CEPT?
What is Average Wholesale Price for ORTHO-CEPT?

Summary for ORTHO-CEPT

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for ORTHO-CEPT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-21	020301-001	Dec 14, 1992		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Janssen Pharms	ORTHO-CEPT	desogestrel; ethinyl estradiol	TABLET;ORAL-28	020301-002	Dec 14, 1992		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ORTHO-CEPT

See the table below for patents covering ORTHO-CEPT around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Switzerland	614453		⤷ Start Trial
United Kingdom	1455270		⤷ Start Trial
Philippines	11191	11,11-ALKYLIDENE STEROIDS	⤷ Start Trial
Canada	1021318	11,11-ALKYLIDENE STEROIDS	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.